Modified Houdek vault applicator for high-dose-rate brachytherapy: a technical report and case series.
brachytherapy
interstitial radiotherapy
intra-cavity radiotherapy
vaginal vault
Journal
Journal of contemporary brachytherapy
ISSN: 1689-832X
Titre abrégé: J Contemp Brachytherapy
Pays: Poland
ID NLM: 101506276
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
08
05
2021
accepted:
06
11
2021
entrez:
26
1
2022
pubmed:
27
1
2022
medline:
27
1
2022
Statut:
ppublish
Résumé
Treatment of isolated post-surgical vault recurrence of cervical and endometrial cancers in previously unirradiated patients includes external beam radiotherapy (EBRT) ± concomitant chemotherapy, followed by brachytherapy (BT) boost. Supra-vaginal component of vault disease often requires interstitial BT for optimal dose coverage. We describe technical details and preliminary case series using modified Houdek vault applicator (MHVA) developed at our institution for limited intra-cavitary plus interstitial high-dose-rate (HDR) vault BT. Nineteen patients with vaginal vault recurrences received BT boost with MHVA between October 2015 and May 2018. All underwent BT application and CT-based BT planning after completion of EBRT ± concomitant chemotherapy. Median EQD MHVA is a simple solution for intra-cavitary and interstitial HDR-BT boost in isolated vault cancers post-surgery, achieving acceptable dosimetric parameters. Preliminary clinical outcomes and late toxicities are satisfactory.
Identifiants
pubmed: 35079251
doi: 10.5114/jcb.2021.112116
pii: 45971
pmc: PMC8782071
doi:
Types de publication
Journal Article
Langues
eng
Pagination
649-654Informations de copyright
Copyright © 2021 Termedia.
Déclaration de conflit d'intérêts
The authors report no conflict of interest.
Références
Oncol Lett. 2010 Jan;1(1):3-11
pubmed: 22966247
J Contemp Brachytherapy. 2017 Jun;9(3):209-215
pubmed: 28725243
Int J Gynaecol Obstet. 1999 Feb;64(2):159-62
pubmed: 10189025
Int J Radiat Oncol Biol Phys. 1998 Jan 15;40(2):421-6
pubmed: 9457831
Int J Gynecol Cancer. 2009 Apr;19(3):314-20
pubmed: 19407552
J Contemp Brachytherapy. 2018 Dec;10(6):559-566
pubmed: 30662479
Anticancer Res. 2013 Jan;33(1):241-7
pubmed: 23267151
Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S241-7
pubmed: 17826824
Gynecol Oncol Rep. 2015 Jan 16;11:26-30
pubmed: 26076091
J Contemp Brachytherapy. 2020 Feb;12(1):17-26
pubmed: 32190066
Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):779-90
pubmed: 11020575
J Contemp Brachytherapy. 2020 Feb;12(1):27-34
pubmed: 32190067
J Contemp Brachytherapy. 2015 Jan;6(4):362-70
pubmed: 25834580
Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):211-9
pubmed: 10219816
Brachytherapy. 2017 Nov - Dec;16(6):1129-1143
pubmed: 28888417
Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1341-6
pubmed: 7713792
Br J Radiol. 2013 Mar;86(1023):20120428
pubmed: 23407428
Brachytherapy. 2014 Jul-Aug;13(4):337-42
pubmed: 24176863
Cancer Treat Rev. 2008 Nov;34(7):603-13
pubmed: 18657909
Br J Radiol. 2010 Jul;83(991):554-68
pubmed: 20603408